Amdocs Stock Current Asset

DOX Stock  USD 89.90  0.52  0.58%   
Amdocs fundamentals help investors to digest information that contributes to Amdocs' financial success or failures. It also enables traders to predict the movement of Amdocs Stock. The fundamental analysis module provides a way to measure Amdocs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amdocs stock.
Other Current Assets is likely to rise to about 307 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 2.6 B in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Amdocs Current Asset Analysis

Amdocs' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total826.8M807.3M928.4M974.8M
Total Assets6.4B6.4B7.4B4.5B

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

More About Current Asset | All Equity Analysis

Current Amdocs Current Asset

    
  2.1 B  
Most of Amdocs' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Amdocs Current Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Amdocs is extremely important. It helps to project a fair market value of Amdocs Stock properly, considering its historical fundamentals such as Current Asset. Since Amdocs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amdocs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amdocs' interrelated accounts and indicators.
0.510.960.20.770.150.930.73-0.610.940.810.040.940.530.950.930.530.92-0.850.56-0.15-0.86-0.59-0.58-0.580.580.52-0.310.33
0.510.320.790.78-0.310.370.71-0.830.670.19-0.230.560.560.510.630.760.6-0.170.87-0.03-0.59-0.66-0.75-0.540.730.85-0.250.61
0.960.32-0.060.670.350.930.66-0.410.80.890.10.90.380.860.830.430.81-0.930.35-0.1-0.82-0.46-0.48-0.460.420.29-0.250.19
0.20.79-0.060.6-0.620.130.53-0.840.48-0.28-0.230.260.410.30.410.640.450.20.85-0.29-0.37-0.7-0.64-0.630.750.83-0.460.59
0.770.780.670.6-0.130.720.95-0.90.810.49-0.070.850.540.750.80.790.81-0.570.88-0.19-0.85-0.81-0.8-0.70.850.75-0.620.67
0.15-0.310.35-0.62-0.130.19-0.010.41-0.080.44-0.210.11-0.35-0.06-0.07-0.09-0.04-0.33-0.450.1-0.060.160.090.19-0.32-0.40.25-0.31
0.930.370.930.130.720.190.74-0.580.830.670.110.920.340.860.870.620.93-0.820.42-0.31-0.89-0.66-0.67-0.680.610.34-0.490.26
0.730.710.660.530.95-0.010.74-0.830.720.44-0.080.80.40.650.760.870.77-0.570.77-0.29-0.88-0.84-0.87-0.760.810.62-0.630.55
-0.61-0.83-0.41-0.84-0.90.41-0.58-0.83-0.76-0.140.13-0.67-0.53-0.64-0.72-0.84-0.780.27-0.920.30.780.880.850.81-0.88-0.80.64-0.61
0.940.670.80.480.81-0.080.830.72-0.760.64-0.050.890.640.950.950.580.93-0.670.75-0.18-0.82-0.67-0.62-0.640.70.73-0.330.46
0.810.190.89-0.280.490.440.670.44-0.140.640.070.720.430.720.630.090.52-0.910.220.21-0.55-0.1-0.12-0.060.110.180.070.12
0.04-0.230.1-0.23-0.07-0.210.11-0.080.13-0.050.070.01-0.07-0.01-0.11-0.170.01-0.13-0.15-0.46-0.06-0.040.160.18-0.08-0.21-0.2-0.15
0.940.560.90.260.850.110.920.8-0.670.890.720.010.470.910.890.620.92-0.780.62-0.16-0.83-0.65-0.67-0.620.740.59-0.480.57
0.530.560.380.410.54-0.350.340.4-0.530.640.43-0.070.470.630.570.230.46-0.340.650.34-0.41-0.3-0.24-0.150.330.52-0.060.35
0.950.510.860.30.75-0.060.860.65-0.640.950.72-0.010.910.630.950.450.89-0.80.64-0.05-0.75-0.52-0.5-0.550.60.59-0.340.43
0.930.630.830.410.8-0.070.870.76-0.720.950.63-0.110.890.570.950.630.91-0.750.68-0.14-0.82-0.63-0.67-0.70.690.64-0.360.42
0.530.760.430.640.79-0.090.620.87-0.840.580.09-0.170.620.230.450.630.73-0.240.66-0.38-0.8-0.89-0.99-0.860.830.56-0.620.46
0.920.60.810.450.81-0.040.930.77-0.780.930.520.010.920.460.890.910.73-0.630.65-0.35-0.89-0.8-0.78-0.790.790.62-0.530.45
-0.85-0.17-0.930.2-0.57-0.33-0.82-0.570.27-0.67-0.91-0.13-0.78-0.34-0.8-0.75-0.24-0.63-0.26-0.030.670.250.280.28-0.25-0.150.18-0.13
0.560.870.350.850.88-0.450.420.77-0.920.750.22-0.150.620.650.640.680.660.65-0.26-0.13-0.61-0.72-0.66-0.60.820.92-0.490.74
-0.15-0.03-0.1-0.29-0.190.1-0.31-0.290.3-0.180.21-0.46-0.160.34-0.05-0.14-0.38-0.35-0.03-0.130.380.620.40.55-0.44-0.180.52-0.02
-0.86-0.59-0.82-0.37-0.85-0.06-0.89-0.880.78-0.82-0.55-0.06-0.83-0.41-0.75-0.82-0.8-0.890.67-0.610.380.840.820.79-0.69-0.470.53-0.25
-0.59-0.66-0.46-0.7-0.810.16-0.66-0.840.88-0.67-0.1-0.04-0.65-0.3-0.52-0.63-0.89-0.80.25-0.720.620.840.910.87-0.87-0.630.73-0.45
-0.58-0.75-0.48-0.64-0.80.09-0.67-0.870.85-0.62-0.120.16-0.67-0.24-0.5-0.67-0.99-0.780.28-0.660.40.820.910.89-0.86-0.580.63-0.47
-0.58-0.54-0.46-0.63-0.70.19-0.68-0.760.81-0.64-0.060.18-0.62-0.15-0.55-0.7-0.86-0.790.28-0.60.550.790.870.89-0.83-0.550.63-0.35
0.580.730.420.750.85-0.320.610.81-0.880.70.11-0.080.740.330.60.690.830.79-0.250.82-0.44-0.69-0.87-0.86-0.830.82-0.730.79
0.520.850.290.830.75-0.40.340.62-0.80.730.18-0.210.590.520.590.640.560.62-0.150.92-0.18-0.47-0.63-0.58-0.550.82-0.320.79
-0.31-0.25-0.25-0.46-0.620.25-0.49-0.630.64-0.330.07-0.2-0.48-0.06-0.34-0.36-0.62-0.530.18-0.490.520.530.730.630.63-0.73-0.32-0.52
0.330.610.190.590.67-0.310.260.55-0.610.460.12-0.150.570.350.430.420.460.45-0.130.74-0.02-0.25-0.45-0.47-0.350.790.79-0.52
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition

Amdocs Total Assets

Total Assets

4.51 Billion

At this time, Amdocs' Total Assets are fairly stable compared to the past year.
In accordance with the recently published financial statements, Amdocs has a Current Asset of 2.1 B. This is 92.58% lower than that of the IT Services sector and significantly higher than that of the Information Technology industry. The current asset for all United States stocks is 77.51% higher than that of the company.

Amdocs Current Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.
Amdocs is currently under evaluation in current asset category among related companies.

Amdocs ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Amdocs Fundamentals

About Amdocs Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amdocs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Non Current Assets Total5.2 B2.6 B
Other Current Assets258.3 M307 M
Total Current Assets2.2 B1.9 B

Amdocs Investors Sentiment

The influence of Amdocs' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amdocs. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Amdocs' public news can be used to forecast risks associated with an investment in Amdocs. The trend in average sentiment can be used to explain how an investor holding Amdocs can time the market purely based on public headlines and social activities around Amdocs. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amdocs' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amdocs' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amdocs' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Amdocs.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amdocs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amdocs' short interest history, or implied volatility extrapolated from Amdocs options trading.

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Moving against Amdocs Stock

  0.75AVPTW AvePointPairCorr
  0.66EGIO Edgio Inc Tech BoostPairCorr
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out Amdocs Piotroski F Score and Amdocs Altman Z Score analysis.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.18
Dividend Share
1.74
Earnings Share
4.68
Revenue Per Share
41.665
Quarterly Revenue Growth
0.05
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.